chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccination on April 4, 2022. When woke up on April 5, 2022, Lymph nodes in her armpit under the same arm that she received her Moderna booster in were all swollen and sore. First vaccination was March 2021 and it was Janssen. She is taking Ibuprofen and using warm compresses to ease the pain.
Pancytopenia, new diagnosis; community-acquired pneumonia - Transfused x3, Hg stable signs without bleeding.  Thrombocytopenia, transfused x1 unit before discharge.  Complete antibiotic course, Levaquin for CAP.  Will follow up with oncology. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Myoclonic sz, intermittant, lasting 15-20min pt brought to ER; presented w/sz as described & sniffely nose, lungs clear; neck supple; afeb-remained lethargic for approx 20min;
on 4/9/21 around 8pm extreme cold chills , headache , body aches fever all night , flu like feeling for 3 days body ache and little sleep , consistent headaches .  Had out patient knee surgery on 4/14 . Continues nasty headaches and body aches after . on saturday 4/17 bad headaches all night , bones in upperbody and skin hurt , from waist up felt like i had sunburn including on top of head , little sleep again . Went to Emergency room on 4/18 am . Tested for blood clot in leg and was negative , they gave me something for headaches and i was dehydrated , tongue was white and continues to wake up everyday white and feeling like dehydration ,  continues head aches from front to back with some continues neck pain in back . Havent slept more than 2 hours at a time . wake up with  headache everyday and at night headaches are bad .  i drink plenty of fluids all day , should not be feeling dehydrated .  its now 15 days since vaccine and have no answers , i need to be able to sleep to do my job , vaccine was a mistake
Rash Rash to bilateral upper extremities, pruritus to bilateral lower extremities, fine, blanching rash Narrative:
1 week after vaccination (4/22/21) patient's arm became red, hot, and had a lump at the vaccination site.  "Covid Arm"
Severely swollen neckline lymph nodes, particularly large on injection site side (2 days after injection, til current ). Bulging along clavicle area, and swollen nodes. Fever (one day after shot, only) and significant redness and soreness around injection site  (2 days after injection)
The first day I felt my ankles hurting, my feet burning like neuralgia pain. Then starting getting shooting pain in my calf then thigh then arms.  Have a slight headache
A nurse reported that a pt received an injection of Typhoid Vaccine, Heat Phenol Inactivated and developed cellulitis at the site of the injection. The pt was treated with dicloxacillin and recovered. This is 1 of several pts from this facility who had an adverse experience following receipt of Typhoid Vaccine, USP, Heat Phenol Inactivated, lot 4998088.
This case was reported by a physician and described the occurrence of sore arm in an adult female subject who was vaccinated with hepatitis B vaccine recombinant (Engerix B) for prophylaxis. On 8/08/2005 the subject received the 1st dose of Engerix B (Lot number not specified) 20 mcg, to an unspecified arm. On the same day as vaccination with Engerix B, the subject experienced a sore arm. At the time of reporting, on 9/07/2005, the event was unresolved.
could not move her arm; Back ache; Bad chill; Fever; Headache; Nausea; lymph node is swollen and painful/could not move her arm; Bad body ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (could not move her arm), BACK PAIN (Back ache), MYALGIA (Bad body ache), CHILLS (Bad chill) and PYREXIA (Fever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021. Concomitant products included LORATADINE (CLARITIN [LORATADINE]), GABAPENTIN and PRAVASTATIN for an unknown indication.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced MYALGIA (Bad body ache). On 09-May-2021, the patient experienced BACK PAIN (Back ache), CHILLS (Bad chill), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and LYMPHADENOPATHY (lymph node is swollen and painful/could not move her arm). On 10-May-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (could not move her arm). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (could not move her arm), BACK PAIN (Back ache), MYALGIA (Bad body ache), CHILLS (Bad chill), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and LYMPHADENOPATHY (lymph node is swollen and painful/could not move her arm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 110 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took Advil as treatment medication for the reported events and feels better.
This spontaneous report was received from a 63 year old female patient, referring on herself. The patient's concurrent conditions and medical history were not reported. On 05-APR-2016, the patient was vaccinated with one dose (also reported as "1 shot") of PNEUMOVAX 23 (route, dose, dose number, anatomical place of vaccination, lot # and expiration date were not provided). Information regarding concomitant therapies was not reported. On the same date, the patient experienced injection site reaction. However, she did not seek for medical attention. Additionally, no product quality complaint was involved. At the time of reporting, the outcome of the injection site reaction was unknown. Also, the causality assessment between PNEUMOVAX 23 and the event was not provided. Additional information has been requested.
to ED c/o hypoxia with AMS, being non-compliant at rehab where he had been dx'd with COVID few days prior; CXR + pneumonia, tx'd with BiPAP, maxipime, solu-medrol, decadron. Pt non compliant and refusing med, bipap, wife wants pt tx'd to hospice, pt expires in hospital prior to discharge
Complete laryngitis occurred on 10/9/09- No other symptoms. Voice began to return on 11/2/09. Hoarseness continues 11/16/ Visits to 3 different mds. Conflicting dx. My symptoms began 48 hrs after I started giving H1N1 vaccine to pediatric patients in health dept. My voice was completely absent for 3 1/2 weeks with continued hoarseness.
Hives . Received epinephrine, steroids, Benadryl and Pepcid. After leaving hospital still had hive (they were slightly improved). Several hours later the hives started to worsen again
SEVERE ARM PAIN THAT SPREAD INTO SHOULDER BLADES, NASEAU, DIZZINESS, EXHAUSTION, SEVER HEAD ACHE, UNABLE TO GO TO WORK THE NEXT DAY.  2 DAYS LATER STILL ARM PAIN AND HEADACHE
Pulmonary Embolism 7/20 presented to ED with right sided pain which he had for about 2 weeks. Denies any hx of trauma. Did admit to moving furniture but did not recall an injury.  D/C'd with chest wall pain and given Ultram 50mg 1 tab q 4hrs qty= 7.  on 7/26 he presented to ED with symptoms of PE and was dx'd with acute PE He was declared deceased on 7/29/21
On June 17, 2021 at 11:20 PM, I noticed 3 small to medium sized gel filled blister on my left side at the bottom of my bra.  The blisters grew over night.  My doctor prescribed a high dosage of Valtrex that I started on June 18, 2021 for 10 days.   The blisters burst on June 19th and left an open wound for about a 1.5 weeks.   it eventually dried up.  I have no recollection and neither does my mother of my ever having chickenpox so having shingles seemed  unrealistic.  Since this incident I have had a number of unexplained issues such as irregular menstrual cycles and tingling in my right arm, hand and foot.
Shortness of breath, chest pain, headache, severe body aches, dizziness, visual disturbance, weakness, fatigue. I have not sought treatment as I'm hoping that it will pass in another day or so.
Started noticing a change in my menstrual cycle the month after the second COVID-19 Moderna vaccine dose.  The periods are now running for nearly three weeks long. The flow is heavy for about a week but there?s still significant spotting in between. I?m now into my third menstrual cycle and it continues to run abnormally long.   I am normally irregular and have been diagnosed with poly cystic ovarian syndrome, but now the periods are running together with hardly any break in between. This has never happened before. I spoke with gynecologist but she said there?s no studies that link the two events (the Moderna COVID-19 vaccine and longer menstrual cycles).   I?ve heard from multiple women who are experiencing similar problems. There?s little data on the subject. Therefore, I would like my experience to help future research into this problem to properly warn women in the future of the potential side effects.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 46 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "Known allergy: Zpack" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
arm soreness after injection;was sore from inoculation; This is a spontaneous report from a contactable consumer reporting for himself. This 74-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL8982, expiry date 31May2021) on 21Jan2021 around 13:00 at 0.3mL single dose intramuscularly in the left arm for COVID-19 vaccination. The patient had asthma which was diagnosed about 6 years ago, as reported on 22Jan2021. He started coughing late 1980s, then got the diagnosis that it was definitely asthma. Concomitant drugs were none, as th patient stated he did not receive any new medications nor had any other recent vaccinations. The patient received the first dose on 21Jan2021 and all he got was soreness in his arm afterwards that went away. He said he was okay, he was sore from inoculation. The event was resolved on an unspecified date in Jan2021 (21Jan2021 or 22Jan2021).
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history and drug allergies were not reported. On 10-MAR-2016 the patient was vaccinated with an expired dose of MMR II (lot # K002528 with expiration date 28-FEB-2016, dose, strength and route unknown). The reporter was not aware of any adverse effects. Additional information has been requested.
pt recv vax 2FEB98 & fail to disclose the face that she was 7mo pregnant to the counseling nurse;
Swollen Lymph node Armpit; Tingly feeling left side of body; Nausea; Fatigue; Dizziness; Chills; Body Aches; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen Lymph node Armpit), PARAESTHESIA (Tingly feeling left side of body), NAUSEA (Nausea), FATIGUE (Fatigue) and DIZZINESS (Dizziness) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen Lymph node Armpit), PARAESTHESIA (Tingly feeling left side of body), NAUSEA (Nausea), FATIGUE (Fatigue), DIZZINESS (Dizziness), CHILLS (Chills), PAIN (Body Aches) and PRURITUS (Itchiness).   At the time of the report, LYMPHADENOPATHY (Swollen Lymph node Armpit), PARAESTHESIA (Tingly feeling left side of body), NAUSEA (Nausea), FATIGUE (Fatigue), DIZZINESS (Dizziness), CHILLS (Chills), PAIN (Body Aches) and PRURITUS (Itchiness) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Patient who had on 1/13/2010 JE #3 and HB #2. He had previously 1/5/2010 H1N1 at work.
My arm was terribly sore after the injection. Then, I had stiffness in my neck so bad that I kept having to change pillows. I couldn't move my neck. This is still going on at this time.
Face felt hot Sinuses felt swollen (open, not closing) Heart racing Difficulty getting deep breath As these symptoms subsided, I developed an intense pain in the center of my lower back. It was constant at first then became  intermittent  before fading away. Each set lasted about 5 minutes.
Severe head shoulder arm and chest pain, extreme fatigue, sore throat lasting more than 48 hours and increased intensity
Beginning the first day she had a fever and severe side effect symptoms. She could not eat and did not get out of bed for two days. She began having severe GI issues (vomiting, nausea, heartburn every single day, Gerd like symptoms) no cause could ever be found. Her muscles and bones hurt badly. She then developed sever headaches and aphasia. She also had tinnitus which is unresolved. Eventually she developed a tic syndrome and still lives with that today. She has occasionally GI symptoms and migraines with aura. She reports more frequent bruising and pain in joints.
Patient and her husband were both getting a Moderna booster and a flu shot.  Patient was given two injections.  Her husband was given his flu shot and it was noticed there was still a flu shot left.  Patient must have been given two boosters, one in each arm.
PATIENT'S WIFE CALLED ABOUT 45MINIUTES AFTER ADMINISTRATION.  HUSBAND IS EXPERIENCING NUMBESS IN FACE AND NECK BUT NO OTHER SYMPTOMS.  I ADVISED THAT IF IT GETS WORSE OR START HAVING OTHER SYMPTOMS, TO GO TO URGENT CARE/ER OTHERWISE TALK TO FAMILY DOCTOR WHEN THEY REOPEN TOMORROW MORNING.  I CALLED THE PATIENT AFTER 30 MINUTES.  SAYS IT IS LIGHTENING UP.
GI bleeding; Walking with a walker; Not Able to Walk; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GASTROINTESTINAL HAEMORRHAGE (GI bleeding) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   No Medical History information was reported.  On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced GASTROINTESTINAL HAEMORRHAGE (GI bleeding) (seriousness criteria hospitalization prolonged and medically significant). On 05-Apr-2021, the patient experienced GAIT INABILITY (Not Able to Walk). On 06-May-2021, the patient experienced WALKING AID USER (Walking with a walker). The patient was hospitalized from 15-Mar-2021 to 05-Apr-2021 due to GASTROINTESTINAL HAEMORRHAGE. The patient was treated with Rehabilitation therapy for Gait inability. At the time of the report, GASTROINTESTINAL HAEMORRHAGE (GI bleeding) outcome was unknown and GAIT INABILITY (Not Able to Walk) and WALKING AID USER (Walking with a walker) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant product use was not provided. On 14 Apr 2021, the patient was moved to Rehab, and after 3 weeks in rehab, she is now walking with a walker. It was reported that the patient has not received the second vaccine yet.  Company Comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Neuralgia symptoms on half of the body at the trunk- like  about to get shingles; Neuralgia is very unusual, extremely painful; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 26Mar2021 at 16:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer, migraine and shingles which occurred once before about 30 years ago. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), rizatriptan (MANUFACTURER UNKNOWN), ubrogepant (UBRELVY) and rimegepant sulfate (NURTEC ODT); all for an unknown indication, from an unknown date and unknown if ongoing. The patient previously took neomycin sulfate/ polymyxin b sulfate/ gramicidin (NEOSPORIN) on an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 05Mar2021 at 16:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 00:00 the patient experienced neuralgia symptoms on half of the body at the trunk-like about to get shingles. The patient did not have blisters, but this neuralgia was very unusual, extremely painful, and had been noticeable for a week. The location and geometry of the pain area was very distinctive and the patient had fear that she might have a shingles outbreak any time. The patient had shingles once before about 30 years ago. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 03Apr2021, since the vaccination the patient underwent lab test and procedures which included SARS CoV-2 test (nasal swab) for COVID- 19 and the result was negative. Since the vaccination, the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event neuralgia symptoms on half of the body at the trunk, like she's about to get shingles and was extremely painful was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient experienced a dry cough and bronchial irritation the morning following the Moderna booster. Patient lost her voice on day 2. She is having difficulty speaking and pushing out air. Her oxygen saturations remain good.
Minor pain at injection site. Malaise during day 9/13, but then had the worst night of my life and feared I was actually going to die. Temperature kept spiking up to 104-105, chills to the point of continual physical shaking/ shuddering, heart racing with fitbit showing 150, could not sleep, extreme weakness, mental fog and couldn't think. Switched to low grade fever and fatigue by about 5 in morning.
Day # 10 after vaccination, he suffered acute myocardial injury. Dx'ed then as perimyocardis
got the vaccine, it gave shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient's siblings for his brother. The age at vaccination was not reported. The patient got the Shingle vaccine and it gave them shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. This case is linked with US2021AMR252710, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR252710:same reporter, other patient
No additional AEs reported; a patient due for her second dose of VARlVAX and was accidently administered PROQUAD instead of VARlVAX; This spontaneous report was received from a medical assistant referring to a 25-year-old female. Information regarding the patient's pertinent medical history, concurrent conditions, and concomitant therapies were not reported.  On 14-JUN-2021, the patient was due for her second dose of varicella virus vaccine live (Oka/Merck) (VARlVAX) for prophylaxis (dose, vaccination scheme, route of administration, anatomical injection site, lot number and expiration date not reported) and was accidently administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) at a dose of 0.5 milliliter for prophylaxis (lot # T021301 has been verified to be valid, expiration date reported and validated as 19-DEC-2021) for prophylaxis (dose number, route of administration, anatomical injection site and vaccination scheme were not reported)  instead (wrong product administered). No additional adverse events (AEs) reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 14Feb2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Course: Patient had received Paxlovid treatment from 20Jul2023 to 24Jul2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300265914 same patient/reporter, different drug/event;
Fever that went up to 104.4, rectally.  Extreme fussiness, rash consisting of scattered blanching pink papules over her body, mainly on trunk and face.  Also significant bluish-red discoloration that is indurated and about 3 x 4 cm at the vaccination injection site.
Immediate regression in development that still has not returned to normal.  Baby no longer able to  wave hello and goodbye as he was consistently before, baby no longer is able to clap hands upon command as before, and no longer puts his hands together in prayer as he consistently was able to before.  Also noticed a lAck of attachment  with myself (mother) anytime I leave or go away, lack of excitement when I return home.